New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2012
19:15 EDTSAM, TELK, RRD, ENDP, HRGOn The Fly: After Hours Movers
UP AFTER GUIDANCE: Boston Beer (SAM), up 12% after raising FY12 EPS view... ALSO HIGHER: Telik (TELK), up 28% after reporting preliminary clinical trial abstract for neutrophina treatment... R.R. Donnelley (RRD), up 3% after first day of trading on the S&P MidCap 400... DOWN AFTER GUIDANCE: Endo Health (ENDP), down 6% after cutting FY12, FY13 EPS views, announcing CEO to retire... ALSO LOWER: Harbiner Group (HRG), down 12% after filing to sell unknown amount of common stock.
News For SAM;TELK;RRD;ENDP;HRG From The Last 14 Days
Check below for free stories on SAM;TELK;RRD;ENDP;HRG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 15, 2014
08:15 EDTTELKTelik to hold a special shareholder meeting
Subscribe for More Information
August 14, 2014
07:46 EDTENDPEndo valuation attractive, says Goldman
Subscribe for More Information
06:34 EDTRRDR.R. Donnelley awarded five year contract by Allianz Insurance
R. R. Donnelley have been awarded a five year, multi-service contract by Allianz Insurance to provide onsite creative design services along with print management and transactional print services.
August 11, 2014
17:40 EDTRRDR.R. Donnelley to take $15M-$20M charge on unit bankruptcy
R.R. Donnelley disclosed in a filing that on Monday, August 11, R.R. Donnelley Argentina S.A., a subsidiary of RR Donnelley & Sons Company, filed for bankruptcy with the Argentine Court due to untenable business conditions. In conjunction with the bankruptcy of its subsidiary, the company expects to record a one-time charge in the range of $15M to $20M; of which approximately half is expected to be cash. These charges will be excluded from the company's non-GAAP earnings. This development does not change the full-year 2014 Guidance included in the company's press release of July 30, which the company reaffirms.
August 8, 2014
09:00 EDTENDPBioDelivery Sciences still a takeover target, says Janney Capital
Janney Capital continues to believe that BioDelivery Sciences (BDSI) could be a takeover target, noting that it thinks partner Endo International (ENDP) could be a potential buyer if BioDelivery has more positive top-line results and if the market weakens. The firm, which added that it likes BioDelivery Sciences as a stand-alone company as well, maintains its Buy rating and $15 fair value estimate on the stock.
08:33 EDTHRGHarbinger Group reports Q3 EPS 28c, compared to 25c a year ago
Reports Q3 revenue $1.6B, compared to $1.4B a year ago.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use